Oxygen Limitation Enhances the Antimicrobial Activity of Fosfomycin in Pseudomonas aeruginosa Following Overexpression of glpT Which Encodes Glycerol-3-Phosphate/Fosfomycin Symporter
Fosfomycin is resurfacing as a “last resort drug” to treat infections caused by multidrug resistant pathogens. This drug has a remarkable benefit in that its activity increases under oxygen-limited conditions unlike other commonly used antimicrobials such as β-lactams, fluoroquinolones and aminoglyc...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-08-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmicb.2018.01950/full |
id |
doaj-ca8a3232b43e427696a4321acfbc64f6 |
---|---|
record_format |
Article |
spelling |
doaj-ca8a3232b43e427696a4321acfbc64f62020-11-25T01:05:21ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2018-08-01910.3389/fmicb.2018.01950400364Oxygen Limitation Enhances the Antimicrobial Activity of Fosfomycin in Pseudomonas aeruginosa Following Overexpression of glpT Which Encodes Glycerol-3-Phosphate/Fosfomycin SymporterHidetada Hirakawa0Kumiko Kurabayashi1Koichi Tanimoto2Haruyoshi Tomita3Haruyoshi Tomita4Department of Bacteriology, Graduate School of Medicine, Gunma University, Maebashi, JapanDepartment of Bacteriology, Graduate School of Medicine, Gunma University, Maebashi, JapanLaboratory of Bacterial Drug Resistance, Graduate School of Medicine, Gunma University, Maebashi, JapanDepartment of Bacteriology, Graduate School of Medicine, Gunma University, Maebashi, JapanLaboratory of Bacterial Drug Resistance, Graduate School of Medicine, Gunma University, Maebashi, JapanFosfomycin is resurfacing as a “last resort drug” to treat infections caused by multidrug resistant pathogens. This drug has a remarkable benefit in that its activity increases under oxygen-limited conditions unlike other commonly used antimicrobials such as β-lactams, fluoroquinolones and aminoglycosides. Especially, utility of fosfomycin has being evaluated with particular interest to treat chronic biofilm infections caused by Pseudomonas aeruginosa because it often encounters anaerobic situations. Here, we showed that P. aeruginosa PAO1, commonly used in many laboratories, becomes more susceptible to fosfomycin when grown anaerobically, and studied on how fosfomycin increases its activity under anaerobic conditions. Results of transport assay and gene expression study indicated that PAO1 cells grown anaerobically exhibit a higher expression of glpT encoding a glycerol-3-phosphate transporter which is responsible for fosfomycin uptake, then lead to increased intracellular accumulation of the drug. Elevated expression of glpT in anaerobic cultures depended on ANR, a transcriptional regulator that is activated under anaerobic conditions. Purified ANR protein bound to the DNA fragment from glpT region upstream, suggesting it is an activator of glpT gene expression. We found that increased susceptibility to fosfomycin was also observed in a clinical isolate which has a promoted biofilm phenotype and its glpT and anr genes are highly conserved with those of PAO1. We conclude that increased antibacterial activity of fosfomycin to P. aeruginosa under anaerobic conditions is attributed to elevated expression of GlpT following activation of ANR, then leads to increased uptake of the drug.https://www.frontiersin.org/article/10.3389/fmicb.2018.01950/fullantimicrobial resistance (AMR)multi-drug resistance (MDR)fosfomycinanaerobiosiscystic fibrosis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hidetada Hirakawa Kumiko Kurabayashi Koichi Tanimoto Haruyoshi Tomita Haruyoshi Tomita |
spellingShingle |
Hidetada Hirakawa Kumiko Kurabayashi Koichi Tanimoto Haruyoshi Tomita Haruyoshi Tomita Oxygen Limitation Enhances the Antimicrobial Activity of Fosfomycin in Pseudomonas aeruginosa Following Overexpression of glpT Which Encodes Glycerol-3-Phosphate/Fosfomycin Symporter Frontiers in Microbiology antimicrobial resistance (AMR) multi-drug resistance (MDR) fosfomycin anaerobiosis cystic fibrosis |
author_facet |
Hidetada Hirakawa Kumiko Kurabayashi Koichi Tanimoto Haruyoshi Tomita Haruyoshi Tomita |
author_sort |
Hidetada Hirakawa |
title |
Oxygen Limitation Enhances the Antimicrobial Activity of Fosfomycin in Pseudomonas aeruginosa Following Overexpression of glpT Which Encodes Glycerol-3-Phosphate/Fosfomycin Symporter |
title_short |
Oxygen Limitation Enhances the Antimicrobial Activity of Fosfomycin in Pseudomonas aeruginosa Following Overexpression of glpT Which Encodes Glycerol-3-Phosphate/Fosfomycin Symporter |
title_full |
Oxygen Limitation Enhances the Antimicrobial Activity of Fosfomycin in Pseudomonas aeruginosa Following Overexpression of glpT Which Encodes Glycerol-3-Phosphate/Fosfomycin Symporter |
title_fullStr |
Oxygen Limitation Enhances the Antimicrobial Activity of Fosfomycin in Pseudomonas aeruginosa Following Overexpression of glpT Which Encodes Glycerol-3-Phosphate/Fosfomycin Symporter |
title_full_unstemmed |
Oxygen Limitation Enhances the Antimicrobial Activity of Fosfomycin in Pseudomonas aeruginosa Following Overexpression of glpT Which Encodes Glycerol-3-Phosphate/Fosfomycin Symporter |
title_sort |
oxygen limitation enhances the antimicrobial activity of fosfomycin in pseudomonas aeruginosa following overexpression of glpt which encodes glycerol-3-phosphate/fosfomycin symporter |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Microbiology |
issn |
1664-302X |
publishDate |
2018-08-01 |
description |
Fosfomycin is resurfacing as a “last resort drug” to treat infections caused by multidrug resistant pathogens. This drug has a remarkable benefit in that its activity increases under oxygen-limited conditions unlike other commonly used antimicrobials such as β-lactams, fluoroquinolones and aminoglycosides. Especially, utility of fosfomycin has being evaluated with particular interest to treat chronic biofilm infections caused by Pseudomonas aeruginosa because it often encounters anaerobic situations. Here, we showed that P. aeruginosa PAO1, commonly used in many laboratories, becomes more susceptible to fosfomycin when grown anaerobically, and studied on how fosfomycin increases its activity under anaerobic conditions. Results of transport assay and gene expression study indicated that PAO1 cells grown anaerobically exhibit a higher expression of glpT encoding a glycerol-3-phosphate transporter which is responsible for fosfomycin uptake, then lead to increased intracellular accumulation of the drug. Elevated expression of glpT in anaerobic cultures depended on ANR, a transcriptional regulator that is activated under anaerobic conditions. Purified ANR protein bound to the DNA fragment from glpT region upstream, suggesting it is an activator of glpT gene expression. We found that increased susceptibility to fosfomycin was also observed in a clinical isolate which has a promoted biofilm phenotype and its glpT and anr genes are highly conserved with those of PAO1. We conclude that increased antibacterial activity of fosfomycin to P. aeruginosa under anaerobic conditions is attributed to elevated expression of GlpT following activation of ANR, then leads to increased uptake of the drug. |
topic |
antimicrobial resistance (AMR) multi-drug resistance (MDR) fosfomycin anaerobiosis cystic fibrosis |
url |
https://www.frontiersin.org/article/10.3389/fmicb.2018.01950/full |
work_keys_str_mv |
AT hidetadahirakawa oxygenlimitationenhancestheantimicrobialactivityoffosfomycininpseudomonasaeruginosafollowingoverexpressionofglptwhichencodesglycerol3phosphatefosfomycinsymporter AT kumikokurabayashi oxygenlimitationenhancestheantimicrobialactivityoffosfomycininpseudomonasaeruginosafollowingoverexpressionofglptwhichencodesglycerol3phosphatefosfomycinsymporter AT koichitanimoto oxygenlimitationenhancestheantimicrobialactivityoffosfomycininpseudomonasaeruginosafollowingoverexpressionofglptwhichencodesglycerol3phosphatefosfomycinsymporter AT haruyoshitomita oxygenlimitationenhancestheantimicrobialactivityoffosfomycininpseudomonasaeruginosafollowingoverexpressionofglptwhichencodesglycerol3phosphatefosfomycinsymporter AT haruyoshitomita oxygenlimitationenhancestheantimicrobialactivityoffosfomycininpseudomonasaeruginosafollowingoverexpressionofglptwhichencodesglycerol3phosphatefosfomycinsymporter |
_version_ |
1725194940430942208 |